Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 77: 1303-1308, 1994;
8750-7587/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woolley, M. J.
Right arrow Articles by O'Byrne, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woolley, M. J.
Right arrow Articles by O'Byrne, P. M.

Journal of Applied Physiology, Vol 77, Issue 3 1303-1308, Copyright © 1994 by American Physiological Society

ARTICLES

Effect of an inhaled corticosteroid on airway eosinophils and allergen-induced airway hyperresponsiveness in dogs

M. J. Woolley, J. Wattie, R. Ellis, C. G. Lane, W. H. Stevens, K. L. Woolley, M. Dahlback and P. M. O'Byrne
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

The presence of airway eosinophils before allergen inhalation may contribute to the development of allergen-induced airway responses. We examined whether a reduction in airway eosinophil numbers before allergen inhalation as a result of inhalation of the corticosteroid budesonide would prevent allergen-induced airway hyperresponsiveness in seven dogs. Acetylcholine airway responsiveness was measured before and 24 h after inhalation of Ascaris suum allergen (10(-6)-10(-2) wt/vol) or its diluent on 4 test days separated by > or = 4 wk. Dogs were pretreated for 7 days before and on the morning of each test day with inhaled budesonide (2.69 mg/day) or a placebo (lactose). Airway eosinophil numbers were assessed by bronchoalveolar lavage. Inhaled budesonide significantly reduced the number of airway eosinophils before allergen inhalation from 3.6 +/- 2.38 x 10(4) (SE) cells/ml after inhaled lactose to 0.3 +/- 0.21 x 10(4) cells/ml after inhaled budesonide (P = 0.028). The decrease in eosinophil number was associated with a significant reduction in allergen-induced airway hyperresponsiveness (P = 0.005). These results support the hypothesis that the number of eosinophils in the airways before allergen inhalation is an important determinant in the development of allergen-induced airway hyperresponsiveness in dogs.


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
C. M. EVANS, D. B. JACOBY, and A. D. FRYER
Effects of Dexamethasone on Antigen-Induced Airway Eosinophilia and M2 Receptor Dysfunction
Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1484 - 1492.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. K. Peachman, D. S. Lyles, and D. A. Bass
Mitochondria in eosinophils: Functional role in apoptosis but not respiration
PNAS, February 13, 2001; 98(4): 1717 - 1722.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. McGrogan, L. J. Janssen, J. Wattie, P. M. O'Byrne, and E. E. Daniel
Release of epithelium-derived PGE2 from canine trachea after antigen inhalation
Am J Physiol Lung Cell Mol Physiol, February 1, 1998; 274(2): L220 - L225.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online